Effects of trastuzumab and lapatinib on HER2 positive breast cancer treatment.

Name: Work Video:
Duration: 3 min 30 s
Description: This study aimed to evaluate the clinical efficacy of trastuzumab combined with lapatinib in the treatment of human epidermal growth factor receptor 2 (HER2) positive breast cancer. One hundred and fifty-four patients with breast cancer were randomly divided into a trastuzumab group (group A, 52 cases), a lapatinib group (group B, 48 cases) and a combination group (group C, 54 cases).
Wei Jia; T Z Wang
{'id': 'https://openalex.org/W2989981638', 'doi': None, 'title': 'Effects of trastuzumab and lapatinib on HER2 positive breast cancer treatment.', 'display_name': 'Effects of trastuzumab and lapatinib on HER2 positive breast cancer treatment.', 'publication_year': 2019, 'publication_date': '2019-03-26', 'ids': {'openalex': 'https://openalex.org/W2989981638', 'mag': '2989981638', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30907562'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30907562', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}, 'type': 'letter', 'type_crossref': 'posted-content', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5105892963', 'display_name': 'Wei Jia', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210097783', 'display_name': 'Tongde Hospital of Zhejiang Province', 'ror': 'https://ror.org/00trnhw76', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210097783']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'W Jia', 'raw_affiliation_strings': ["Department of Clinnical Pharmacy, Tonglu First People's Hospital, Zhejiang, Tonglu, Hangzhou, Zhejiang, China, e-mail: [email protected]."], 'affiliations': [{'raw_affiliation_string': "Department of Clinnical Pharmacy, Tonglu First People's Hospital, Zhejiang, Tonglu, Hangzhou, Zhejiang, China, e-mail: [email protected].", 'institution_ids': ['https://openalex.org/I4210097783']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5020916195', 'display_name': 'T Z Wang', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210097783', 'display_name': 'Tongde Hospital of Zhejiang Province', 'ror': 'https://ror.org/00trnhw76', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210097783']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'T Z Wang', 'raw_affiliation_strings': ["Department of Orthopedics, Tonglu First People's Hospital, Tonglu, Hangzhou, Zhejiang, China."], 'affiliations': [{'raw_affiliation_string': "Department of Orthopedics, Tonglu First People's Hospital, Tonglu, Hangzhou, Zhejiang, China.", 'institution_ids': ['https://openalex.org/I4210097783']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': None, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.295557, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 61, 'max': 69}, 'biblio': {'volume': '33', 'issue': '2', 'first_page': '551', 'last_page': '555'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10755', 'display_name': 'HER2/EGFR in Cancer Research', 'score': 0.9984, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11016', 'display_name': 'Monoclonal and Polyclonal Antibodies Research', 'score': 0.9754, 'subfield': {'id': 'https://openalex.org/subfields/2741', 'display_name': 'Radiology, Nuclear Medicine and Imaging'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9726, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/lapatinib', 'display_name': 'Lapatinib', 'score': 0.98525167}], 'concepts': [{'id': 'https://openalex.org/C2777329042', 'wikidata': 'https://www.wikidata.org/wiki/Q420323', 'display_name': 'Lapatinib', 'level': 5, 'score': 0.98525167}, {'id': 'https://openalex.org/C2779786085', 'wikidata': 'https://www.wikidata.org/wiki/Q412616', 'display_name': 'Trastuzumab', 'level': 4, 'score': 0.97131264}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.81273973}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.67080754}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.64933324}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.61711746}, {'id': 'https://openalex.org/C2908728163', 'wikidata': 'https://www.wikidata.org/wiki/Q415271', 'display_name': 'Human Epidermal Growth Factor Receptor 2', 'level': 4, 'score': 0.5098545}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.42154533}], 'mesh': [{'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000077341', 'descriptor_name': 'Lapatinib', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D018719', 'descriptor_name': 'Receptor, ErbB-2', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': True}, {'descriptor_ui': 'D000068878', 'descriptor_name': 'Trastuzumab', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000970', 'descriptor_name': 'Antineoplastic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}, {'descriptor_ui': 'D000074322', 'descriptor_name': 'Antineoplastic Agents, Immunological', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001943', 'descriptor_name': 'Breast Neoplasms', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077341', 'descriptor_name': 'Lapatinib', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018719', 'descriptor_name': 'Receptor, ErbB-2', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068878', 'descriptor_name': 'Trastuzumab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30907562', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'submittedVersion', 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'score': 0.86, 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4249936571', 'https://openalex.org/W2994476032', 'https://openalex.org/W2989981638', 'https://openalex.org/W2896532861', 'https://openalex.org/W2551107202', 'https://openalex.org/W2512440162', 'https://openalex.org/W2338354381', 'https://openalex.org/W2166317024', 'https://openalex.org/W2096496632', 'https://openalex.org/W111573635'], 'abstract_inverted_index': {'This': [0], 'study': [1], 'aimed': [2], 'to': [3], 'evaluate': [4], 'the': [5, 14], 'clinical': [6], 'efficacy': [7], 'of': [8, 16], 'trastuzumab': [9, 40], 'combined': [10], 'with': [11, 32], 'lapatinib': [12, 47], 'in': [13], 'treatment': [15], 'human': [17], 'epidermal': [18], 'growth': [19], 'factor': [20], 'receptor': [21], '2': [22], '(HER2)': [23], 'positive': [24], 'breast': [25, 33], 'cancer.': [26], 'One': [27], 'hundred': [28], 'and': [29, 53], 'fifty-four': [30], 'patients': [31], 'cancer': [34], 'were': [35], 'randomly': [36], 'divided': [37], 'into': [38], 'a': [39, 46, 54], 'group': [41, 48, 56], '(group': [42, 49, 57], 'A,': [43], '52': [44], 'cases),': [45], 'B,': [50], '48': [51], 'cases)': [52], 'combination': [55], 'C,': [58], '54': [59], 'cases).': [60]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2989981638', 'counts_by_year': [{'year': 2019, 'cited_by_count': 1}], 'updated_date': '2024-12-14T00:24:17.648699', 'created_date': '2019-12-05'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
